Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Pharmaceutical Alliance Management (PH119)

Pharmaceutical Alliance Management (PH119)

Drive revenue through alliance success:

Nearly half of today’s top-selling drugs were the result of partnerships. Companies across the industry annually spend hundreds of millions of dollars to utilize other firms’ discovery, development and marketing capabilities in their quests for the next blockbusters.

This pressure to maintain strong portfolios underscores the importance of alliance management. Alliance management is a crucial step in the deal-making process. But it is here that many deals fall apart. At this stage, the burden rests on alliance management personnel to keep things running smoothly. Ensuring a thriving collaboration is a daunting responsibility requiring many parts — ample organizational support, efficient project coordination, and constant, open communication.

Companies that excel in alliance management position themselves to win new deals. Those organizations that show a penchant for successful collaborations will attract other companies looking for strong allies — in the process filling critical portfolio holes and penetrating exciting new markets.

Pharmaceutical Alliance Management focuses on overcoming post-deal management challenges. Findings and interviews with pharma and biotech industry leaders provide proven, successful approaches for partnership success. The report instructs alliance managers on how to:

• Develop a robust alliance management strategy

• Gain key stakeholders’ support and organizational resources

• Cultivate deeply rooted partner relationships

• Identify and eliminate problem areas

• Monitor alliance health

• Attain partner-of-choice status

Companies Included in Report

Abbott Labs

Ablynx

ADVENTRX Pharmaceuticals

Allergan

Altus

Amgen

Amylin

AstraZeneca

Bayer Schering

Biogen Idec

Boehringer-Ingelheim

Bristol-Myers Squibb

Caprion Proteomics

Celgene

Cancer Research Technology

Compugen

CytRx

DSM

Eisai

Eli Lilly

Epix

Eurand

Genentech

GlaxoSmithKline

Implicit Bioscience

Janssen-Cilag

King Pharmaceuticals

Lexicon

MedImmune

Merck & Co.

Merck Serono

Nerviano Medical Sciences

Neurochem

Neurogen

Novartis

Novo Nordisk

NPS

Onyx

Pfizer

Primus

Procter & Gamble

Purdue Pharma

Roche

Sanofi-Aventis

Solvay

Valeant Canada

Vifor

Published 2008

87 Pages

150+ Metrics
Table of Contents
Price: $5,995.00 / €4,010.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions